India's Biological E. to start vaccine late-stage trials in April: Executive

The privately held company said in November it had started early-stage and mid-stage human trials of its vaccine candidate, being developed in collaboration with Baylor College of Medicine in Houston and U.S.-based Dynavax Technologies Corp, and expects results by February.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/38fAsrJ
via IFTTT